Literature DB >> 21494403

Nutritive Supplements - Help or Harm for Breast Cancer Patients?

Karsten Muenstedt1, Samer El-Safadi.   

Abstract

SUMMARY: Considerable numbers of patients and physicians believe that micronutrients may be useful with respect to prevention and treatment of breast cancer. However, the analysis of the literature shows that basic information on nutritional demands in cancer patients is lacking. It is unknown whether there is an increased demand of micro-nutrients in cancer patients in general and if there is an even more increased demand during the various types of treatment. As a result, there are only limited positive findings. Higher calcium intake in premenopausal women and higher intake of vitamin D seem to be able to lower breast cancer incidence. Vitamin E (800 IU per day) was found to have a modest effect on hot flashes during tamoxifen treatment. However, there are potential side effects especially when micronutrients are administered in high or very high doses. There is increasing evidence that dose-effect relationships are not linear but U-shaped. It seems that two thresholds exist for adverse effect, one at low doses for undersupply, and another at high doses for toxicity. Thus, arbitrary high-dose administration of micronutrients should be avoided. Supplementation of normal doses seems to be safe and acceptable from the medical point of view.

Entities:  

Year:  2010        PMID: 21494403      PMCID: PMC3076350          DOI: 10.1159/000322651

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN: 1661-3791            Impact factor:   2.860


  30 in total

1.  Folate and risk of breast cancer: a meta-analysis.

Authors:  Susanna C Larsson; Edward Giovannucci; Alicja Wolk
Journal:  J Natl Cancer Inst       Date:  2007-01-03       Impact factor: 13.506

2.  U-shaped dose-response curves: implications for risk characterization of essential elements and other chemicals.

Authors:  Michael Douron
Journal:  J Toxicol Environ Health A       Date:  2010

Review 3.  Trace elements and cancer risk: a review of the epidemiologic evidence.

Authors:  Stephanie A Navarro Silvera; Thomas E Rohan
Journal:  Cancer Causes Control       Date:  2007-02       Impact factor: 2.506

4.  Mega-dose vitamins and minerals in the treatment of non-metastatic breast cancer: an historical cohort study.

Authors:  M L Lesperance; I A Olivotto; N Forde; Y Zhao; C Speers; H Foster; M Tsao; N MacPherson; A Hoffer
Journal:  Breast Cancer Res Treat       Date:  2002-11       Impact factor: 4.872

5.  Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer.

Authors:  Pamela J Goodwin; Marguerite Ennis; Kathleen I Pritchard; Jarley Koo; Nicky Hood
Journal:  J Clin Oncol       Date:  2009-05-18       Impact factor: 44.544

Review 6.  Beta-carotene supplementation and cancer risk: a systematic review and metaanalysis of randomized controlled trials.

Authors:  Nathalie Druesne-Pecollo; Paule Latino-Martel; Teresa Norat; Emilie Barrandon; Sandrine Bertrais; Pilar Galan; Serge Hercberg
Journal:  Int J Cancer       Date:  2010-07-01       Impact factor: 7.396

7.  Intake of vitamin D and risk of breast cancer--a meta-analysis.

Authors:  Tina Gissel; Lars Rejnmark; Leif Mosekilde; Peter Vestergaard
Journal:  J Steroid Biochem Mol Biol       Date:  2008-06-11       Impact factor: 4.292

Review 8.  Vitamin D, aging, and cancer.

Authors:  Pentti Tuohimaa
Journal:  Nutr Rev       Date:  2008-10       Impact factor: 7.110

Review 9.  Antioxidants and cancer therapy: a systematic review.

Authors:  Elena J Ladas; Judith S Jacobson; Deborah D Kennedy; Katherine Teel; Aaron Fleischauer; Kara M Kelly
Journal:  J Clin Oncol       Date:  2004-02-01       Impact factor: 44.544

Review 10.  Ingestion of selenium and other antioxidants during prostate cancer radiotherapy: a good thing?

Authors:  A Tabassum; R G Bristow; V Venkateswaran
Journal:  Cancer Treat Rev       Date:  2010-01-15       Impact factor: 12.111

View more
  1 in total

1.  25-Hydroxyvitamin D and TSH as Risk Factors or Prognostic Markers in Thyroid Carcinoma.

Authors:  Debora Lucia Seguro Danilovic; Bruno Ferraz-de-Souza; Amanda Wictky Fabri; Nathalie Oliveira Santana; Marco Aurelio Kulcsar; Claudio Roberto Cernea; Suemi Marui; Ana Oliveira Hoff
Journal:  PLoS One       Date:  2016-10-13       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.